Literature DB >> 27076446

Cellular Changes Consistent With Epithelial-Mesenchymal Transition and Fibroblast-to-Myofibroblast Transdifferentiation in the Progression of Experimental Endometriosis in Baboons.

Qi Zhang1, Jie Duan1, Mark Olson2, Asgerally Fazleabas3, Sun-Wei Guo4.   

Abstract

We have recently shown that platelets play important roles in development of endometriosis and proposed that endometriotic lesions are essentially wounds that undergo repeated tissue injury and repair (ReTIAR). Further investigation indicated that endometriotic lesions, stimulated by platelet-derived transforming growth factor β1 (TGF-β1), activate the TGF-β1/Smad3 signaling pathway and undergo epithelial-mesenchymal transition (EMT) and fibroblast-to-myofibroblast transdifferentiation (FMT), resulting in increased cellular contractility and collagen production and increased smooth muscle metaplasia (SMM), leading to fibrosis. Using serially dissected endometriotic tissue samples from baboons with induced endometriosis, we tested the hypothesis of progressive EMT, FMT, SMM, and fibrosis through TGF-β1/Smad activation using immunohistochemistry and immunoflurescence staining analyses. We found that platelets are aggregated in endometriotic lesions, and vimentin expression was increased in the epithelial compartment of the lesions as they progressively developed. We also found that the number of smooth muscle cells (SMCs) appeared to increase with time as lesions progressed and was concomitant with the increased vimentin-positive glandular epithelial cells in the lesions. As lesion development progressed, TGF-β1 and phosphorylated-Smad3 staining was elevated and the number of α-smooth muscle actin-positive myofibroblasts and highly differentiated SMCs increased in the stromal compartment, which correlated with the increasing extent of fibrosis. These results, taken together, provide support for the notion that ReTIAR occurs in the endometriotic lesions, resulting in EMT and FMT, leading to SMM and ultimately fibrosis as lesions progress. Consequently, our data also provide corroborative evidence that platelets drive the EMT and FMT in endometriotic lesions over time, promoting SMM and resulting ultimately in fibrosis in the endometriotic lesions. These findings cast a new light on the natural history of endometriosis which so far has been elusive.
© The Author(s) 2016.

Entities:  

Keywords:  Smad3; TGF-β1; baboon; endometriosis; epithelial–mesenchymal transition; fibroblast-to-myofibroblast transdifferentiation; fibrosis; smooth muscle metaplasia

Mesh:

Substances:

Year:  2016        PMID: 27076446      PMCID: PMC5933178          DOI: 10.1177/1933719116641763

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  43 in total

Review 1.  Endometriosis.

Authors:  Linda C Giudice; Lee C Kao
Journal:  Lancet       Date:  2004 Nov 13-19       Impact factor: 79.321

Review 2.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

3.  Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis.

Authors:  Xishi Liu; Minhong Shen; Qiuming Qi; Hongqi Zhang; Sun-Wei Guo
Journal:  Hum Reprod       Date:  2016-02-22       Impact factor: 6.918

4.  Pleuro-pulmonary endometriosis and pulmonary ectopic deciduosis: a clinicopathologic and immunohistochemical study of 10 cases with emphasis on diagnostic pitfalls.

Authors:  D B Flieder; C A Moran; W D Travis; M N Koss; E J Mark
Journal:  Hum Pathol       Date:  1998-12       Impact factor: 3.466

5.  P-selectin as a potential therapeutic target for endometriosis.

Authors:  Sun-Wei Guo; Ding Ding; Jian-Guo Geng; Lijing Wang; Xishi Liu
Journal:  Fertil Steril       Date:  2015-02-11       Impact factor: 7.329

6.  Oxytocin receptor expression in smooth muscle cells of peritoneal endometriotic lesions and ovarian endometriotic cysts.

Authors:  Sylvia Mechsner; Julia Bartley; Christoph Loddenkemper; David S Salomon; Anna Starzinski-Powitz; Andreas D Ebert
Journal:  Fertil Steril       Date:  2005-04       Impact factor: 7.329

7.  A comparative study of ovarian and pelvic wall-infiltrating endometriosis.

Authors:  V K Khare; D C Martin; M Eltorky
Journal:  J Am Assoc Gynecol Laparosc       Date:  1996-02

8.  Dating Endometriotic Ovarian Cysts Based on the Content of Cyst Fluid and its Potential Clinical Implications.

Authors:  Sun-Wei Guo; Ding Ding; Minhong Shen; Xishi Liu
Journal:  Reprod Sci       Date:  2015-02-11       Impact factor: 3.060

9.  Changes in eutopic endometrial gene expression during the progression of experimental endometriosis in the baboon, Papio anubis.

Authors:  Yalda Afshar; Julie Hastings; Damian Roqueiro; Jae-Wook Jeong; Linda C Giudice; Asgerally T Fazleabas
Journal:  Biol Reprod       Date:  2013-02-21       Impact factor: 4.285

10.  The pathophysiology of endometriosis and adenomyosis: tissue injury and repair.

Authors:  G Leyendecker; L Wildt; G Mall
Journal:  Arch Gynecol Obstet       Date:  2009-07-31       Impact factor: 2.344

View more
  24 in total

1.  Activation of α7 nicotinic acetylcholine receptor retards the development of endometriosis.

Authors:  Meihua Hao; Xishi Liu; Sun-Wei Guo
Journal:  Reprod Biol Endocrinol       Date:  2022-06-04       Impact factor: 4.982

2.  Serum MicroRNA Biomarkers Regulated by Simvastatin in a Primate Model of Endometriosis.

Authors:  Emine Cosar; Ramanaiah Mamillapalli; Irene Moridi; Antoni Duleba; Hugh S Taylor
Journal:  Reprod Sci       Date:  2018-03-27       Impact factor: 3.060

3.  Anti-platelet therapy holds promises in treating adenomyosis: experimental evidence.

Authors:  Bo Zhu; Yumei Chen; Xiaolu Shen; Xishi Liu; Sun-Wei Guo
Journal:  Reprod Biol Endocrinol       Date:  2016-10-10       Impact factor: 5.211

Review 4.  Epithelial-to-mesenchymal transition in the development of endometriosis.

Authors:  Yan-Meng Yang; Wan-Xi Yang
Journal:  Oncotarget       Date:  2017-06-20

5.  Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis.

Authors:  Qi Zhang; Peixin Dong; Xishi Liu; Noriaki Sakuragi; Sun-Wei Guo
Journal:  Sci Rep       Date:  2017-07-28       Impact factor: 4.379

6.  Plasma High Mobility Group Box 1 (HMGB1), Osteopontin (OPN), and Hyaluronic Acid (HA) as Admissible Biomarkers for Endometriosis.

Authors:  Yunlei Cao; Xishi Liu; Sun-Wei Guo
Journal:  Sci Rep       Date:  2019-06-25       Impact factor: 4.379

7.  Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis.

Authors:  Dingmin Yan; Xishi Liu; Sun-Wei Guo
Journal:  Sci Rep       Date:  2019-02-25       Impact factor: 4.379

8.  Exploration of the Modulatory Property Mechanism of ELeng Capsule in the Treatment of Endometriosis Using Transcriptomics Combined With Systems Network Pharmacology.

Authors:  Weilin Zheng; Jie Wang; Jiayi Wu; Tao Wang; Yangxue Huang; Xuefang Liang; Lixing Cao
Journal:  Front Pharmacol       Date:  2021-06-18       Impact factor: 5.810

9.  Bioinformatic analysis reveals the importance of epithelial-mesenchymal transition in the development of endometriosis.

Authors:  Meihong Chen; Yilu Zhou; Hong Xu; Charlotte Hill; Rob M Ewing; Deming He; Xiaoling Zhang; Yihua Wang
Journal:  Sci Rep       Date:  2020-05-21       Impact factor: 4.379

Review 10.  Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis.

Authors:  Sun-Wei Guo
Journal:  Reprod Med Biol       Date:  2018-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.